UK markets closed

Shenyang Xingqi Pharmaceutical Co.,Ltd. (300573.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
171.18+0.68 (+0.40%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 29.86B
Enterprise value 29.40B
Trailing P/E 116.90
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.59
Price/book (mrq)17.19
Enterprise value/revenue 19.20
Enterprise value/EBITDA 102.56

Trading information

Stock price history

Beta (5Y monthly) -0.05
52-week change 368.89%
S&P500 52-week change 326.24%
52-week high 3214.36
52-week low 380.17
50-day moving average 3186.09
200-day moving average 3136.20

Share statistics

Avg vol (3-month) 33.95M
Avg vol (10-day) 33.57M
Shares outstanding 5174.42M
Implied shares outstanding 6181.26M
Float 8120.51M
% held by insiders 134.04%
% held by institutions 118.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46
Forward annual dividend yield 43.51%
Trailing annual dividend rate 32.86
Trailing annual dividend yield 31.68%
5-year average dividend yield 40.51
Payout ratio 483.62%
Dividend date 3N/A
Ex-dividend date 422 May 2024
Last split factor 21.4:1
Last split date 322 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 16.69%
Operating margin (ttm)11.22%

Management effectiveness

Return on assets (ttm)8.63%
Return on equity (ttm)15.41%

Income statement

Revenue (ttm)1.53B
Revenue per share (ttm)8.74
Quarterly revenue growth (yoy)22.10%
Gross profit (ttm)N/A
EBITDA 353.83M
Net income avi to common (ttm)255.44M
Diluted EPS (ttm)1.47
Quarterly earnings growth (yoy)79.60%

Balance sheet

Total cash (mrq)567.85M
Total cash per share (mrq)3.26
Total debt (mrq)109.8M
Total debt/equity (mrq)6.32%
Current ratio (mrq)3.12
Book value per share (mrq)9.96

Cash flow statement

Operating cash flow (ttm)342.67M
Levered free cash flow (ttm)75.14M